International recognition of WhartoCell: A Royan Institute cell therapy achievement
✨ AI Summary
MedPath, an international platform covering medical information and health technology, has published a report on WhartoCell, a cell therapy product developed by Iran's Royan Institute. The report follows the product through its development and approval. For the institute, the international coverage amounts to recognition of a homegrown therapy.
MedPath, an international platform specializing in medical information, clinical trials, and health technologies, has published a report highlighting the development and approval of WhartoCell, a cell therapy product developed by Royan Institute.
Read full article →